IBX — Imagion Biosystems Cashflow Statement
0.000.00%
- AU$2.74m
- AU$8.55m
- AU$1.44m
Annual cashflow statement for Imagion Biosystems, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 2.08 | 2.2 | 2.63 | 2.55 | 3.6 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.18 | -4.62 | -5.07 | -8.07 | -8.32 |
Capital Expenditures | -0.012 | -0.008 | -0.31 | -0.507 | -0.19 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | 0.039 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.012 | -0.008 | -0.31 | -0.469 | -0.19 |
Financing Cash Flow Items | -0.013 | -1.11 | -0.006 | 0 | -0.619 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.33 | 14.5 | 5.15 | -0.962 | 4.29 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.965 | 9.8 | 0.193 | -8.95 | -4.22 |